2 Gaining & 2 Losser Stock Update (APRI, RAD, DVAX, ROVI)

New York, NY -- (SBWIRE) -- 06/10/2013 -- Apricus Biosciences, Inc. (NASDAQ: APRI) is expecting to expand its investment platform considerably. The company is sailing a mix of common inventory and should get that it desires will increase net continues of nearly $16 thousand. Six thousand stocks will be marketed in an underwritten community providing at $2.85 each, and 3 thousand should get will be released independently at an exercise price of $3.40 per discuss.